Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
08/08/2025 14:07
Aug 8 (Reuters) - Oncolytics Biotech Inc ONC.TO: ONCOLYTICS BIOTECH® ANNOUNCES VOLUNTARY DELISTING FROM THE TORONTO STOCK EXCHANGE ONCOLYTICS BIOTECH INC - DELISTING FROM TSX WILL NOT AFFECT NASDAQ LISTING Source text: ID:nPnbQXlH1a Further company coverage: ONC.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer